This is a StreetInsider.com Premium Only Page

Vermillion (VRML) – Company Press Releases

Mar 23, 2022 07:00 AM Aspira Women’s Health Reports Fourth Quarter and Full Year 2021 Financial Results

May 5, 2021 08:00 AM Aspira Women’s Health Inc. to Report First Quarter 2021 Financial Results on May 13

Sep 8, 2020 11:44 AM Aspira Women’s Health, Inc. to Present at Cantor Virtual Healthcare Conference

Aug 14, 2020 03:51 PM UPDATE – Aspira Women’s Health Reports Second Quarter 2020 Financial Results

Aug 13, 2020 04:01 PM Aspira Women’s Health Reports Second Quarter 2020 Financial Results

Jul 31, 2020 09:23 AM Aspira Women’s Health, Inc. to Report Second Quarter 2020 Financial Results on August 13th

Jul 1, 2020 11:23 AM Aspira Women’s Health Inc. Announces Equity Financing of Approximately $11 Million

Jun 29, 2020 08:00 AM Aspira Women’s Health, Inc. Announces First Patient Enrolled in Prospective OVANex Study for Benign Pelvic Mass Monitoring

Jun 11, 2020 08:31 AM Vermillion, Inc. Announces Rebranding and Company Name Change to Aspira Women’s Health Inc.

Jun 10, 2020 08:00 AM Vermillion Completes Validation of New Pre-Surgical Test Offerings with OVA1®plus, including COVID-19 Antibody Testing and Additional Pelvic Mass Risk Assessment Biomarkers

Jun 9, 2020 04:34 PM Vermillion Set to Join Russell 3000® Index

May 14, 2020 04:01 PM Vermillion Reports First Quarter 2020 Financial Results

Apr 30, 2020 04:01 PM Vermillion to Report First Quarter 2020 Financial Results on May 14

Apr 14, 2020 08:00 AM Vermillion Inc. Announces ASPiRA LABS Now Credentialed as Florida State Medicaid Provider

Mar 27, 2020 08:00 AM Vermillion Announces Cigna Preferred Contract Coverage for OVA1, Overa and Genetics Testing

Mar 26, 2020 04:01 PM Vermillion Reports Fourth Quarter 2019 Financial Results

Mar 4, 2020 08:00 AM Vermillion to Participate in Statewide “Women and Girls Day” at the Connecticut State Capital on March 6, 2020

Mar 3, 2020 08:00 AM Vermillion to Report Fourth Quarter 2019 Financial Results on March 26

Feb 25, 2020 04:01 PM Vermillion to Participate at the 32nd Annual Roth Conference

Jan 9, 2020 04:05 PM Chembio Diagnostics Announces CEO Transition

Jan 2, 2020 04:05 PM Vermillion to Present at 2020 Biotech Showcase; Participate in LifeSci Advisors Corporate Access Event

Dec 17, 2019 08:00 AM Vermillion, Inc. and Einstein Medical Center Philadelphia Announce the First Patient Enrolled in Prospective National Clinical Study of Ovarian Cancer Risk Detection Methods in African American Women

Dec 3, 2019 06:00 AM GenomeSmartTM and ASPiRA LABS®, a Vermillion Company, Launch Pilot Program to Improve Access to Genetic Testing

Nov 21, 2019 08:00 AM Vermillion to Participate at the Piper Jaffray 31st Annual Healthcare Conference

Nov 12, 2019 04:05 PM Vermillion Reports Third Quarter 2019 Financial Results

Oct 8, 2019 04:15 PM Vermillion to Report Third Quarter 2019 Financial Results on November 12

Sep 30, 2019 08:00 AM Vermillion to Participate at 2019 Cantor Global Healthcare Conference

Sep 4, 2019 08:00 AM Vermillion Announces Two Independent Publications Showing OVA1® (MIA- Multivariate Index Assay) Demonstrates Improved Ovarian Malignancy Risk Detection in African-American Women

Aug 8, 2019 04:05 PM Vermillion Reports Second Quarter 2019 Financial Results

Jul 31, 2019 04:01 PM Vermillion to Report Second Quarter 2019 Financial Results on August 8

Jul 16, 2019 08:00 AM Vermillion Announces Publication of New Study Demonstrating Overa’s Greater Sensitivity in Detecting Ovarian Cancer Compared with ROMA, HE4 + CA125, and CA125 Alone

Jun 26, 2019 09:14 AM Vermillion, Inc. Announces Pricing of $15 Million Public Offering of Common Stock

Jun 25, 2019 04:01 PM Vermillion, Inc. Announces Proposed Public Offering of Common Stock

Jun 20, 2019 06:33 PM Vermillion Adds Two Major Contracted Agreements for OVA1

May 14, 2019 04:05 PM Vermillion Reports First Quarter 2019 Financial Results

May 13, 2019 04:01 PM Vermillion Announces Acceptance of Publication Ethnic Disparity Data Showing OVA1® (MIA) Superiority over CA125 and HE4 in Detecting Ovarian Cancer Risk

Apr 22, 2019 10:07 AM Vermillion to Report First Quarter 2019 Financial Results on May 14

Apr 2, 2019 04:20 PM Vermillion Exhibits OVA1 Ethnic Disparity Performance Poster at the American Association for Cancer Research (AACR) Annual Meeting

Mar 28, 2019 04:01 PM Vermillion Reports Fourth Quarter and Year-End 2018 Financial Results

Mar 12, 2019 12:27 PM Vermillion to Report Fourth Quarter and Year End 2018 Financial Results on Thursday, March 28

Jan 15, 2019 09:46 AM Vermillion Announces Coverage by Cigna for OVA1® (MIA)

Nov 20, 2018 04:01 PM Vermillion to Present at the Piper Jaffray 30th Annual Healthcare Conference

Nov 12, 2018 08:00 AM Vermillion to Present at the Canaccord Medical Technology & Diagnostics Forum

Nov 8, 2018 04:01 PM Vermillion Announces OVA1® (MIA) and OVERA® (MIA2G) Study and Coverage by Clalit Health Services in Israel

Nov 8, 2018 04:01 PM Vermillion Reports Third Quarter 2018 Financial Results

Oct 26, 2018 04:05 PM Vermillion to Report Third Quarter and Nine Months Ended September 30, 2018 Financial Results on Thursday, November 8

Oct 9, 2018 08:00 AM Vermillion, Inc. Announces the Launch of OVA1®+

Sep 6, 2018 09:00 AM Vermillion, Inc. Kicks Off Ovarian Cancer Awareness Month by Ringing the NASDAQ Closing Bell

Aug 21, 2018 04:01 PM Vermillion, Inc. Appoints Nancy Cocozza to its Board of Directors

Aug 9, 2018 04:01 PM Vermillion Reports Second Quarter 2018 Financial Results